Injection Drug Users (IDUs) / Substance Abusers (Printable Version)
Sharing syringes and other equipment for drug injection is a well-known route of HIV transmission, yet injection drug use contributes to the epidemic's spread far beyond the circle of those who inject.1Injection drug users, their partners, and their children account for at least 36% of all AIDS cases reported in the United States through 1999.2
Racial and ethnic minority populations in the United States are most heavily affected by IDU-associated AIDS. In 2000, IDU-associated AIDS accounted for 26% of all AIDS cases among African American and 31% among Hispanic adults and adolescents, compared with 19% of all cases among white adults/adolescents.3
IDU-associated AIDS accounts for a larger proportion of cases among adolescent and adult women than among men. Since the epidemic began, 57% of all AIDS cases among women have been attributed to injection drug use or sex with partners who inject drugs, compared with 31% of cases among men.4
Featured Links
Best Practices in TB Control: Working with Substance Users and Homeless Populations
From the New Jersey Medical School Global Tuberculosis Institute
MMWR: Syringe Exchange Programs—United States, 2005
From CDC’s MMWR Weekly November 9, 2007 / 56(44);1164-1167
HIV Testing Survey, 2000, HIV/AIDS Special Surveillance Report, Volume 1, Number 1, September, 2003 [HTML] [PDF]
HIV/AIDS Surveillance Supplemental Report from the Division of HIV/AIDS Prevention of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. This report focuses on HIV testing patterns and risk behaviors among three groups at high risk for HIV infection. Data in this report comes from the HIV Testing Survey (HITS), conducted in seven states and New York City in 2000.
HIV Diagnoses Among
Injection-Drug Users in States with HIV Surveillance--25 States, 1994-2000
MMWR: July 11, 2003 / Vol. 52 / 27:634-636
Principles of HIV Prevention in Drug-Using Populations
Manual produced by the National Institute on Drug Abuse (NIDA)
Drug-Associated HIV Transmission Continues in the United States
Fact sheet from the Division of HIV/AIDS Prevention of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Crisis Among Gay Men: Crystal Methamphetamine Use Linked to Rising HIV and STD Rates
Fact Sheet from The National Alliance of State and Territorial AIDS Directors (NASTAD) and the National Coalition of STD Directors (NCSD)
What are Substance Abusers HIV Prevention Needs?
From Center for AIDS Prevention Studies, University of California at San Francisco
http://www.caps.ucsf.edu/pubs/FS/substancetext.php
Working with the Active User
Fact sheet from HIV Clinical Resource
HIV and Substance Abuse Clinical Guidelines
Fact sheets from HIV Clinical Resource
Hepatitis B Vaccination for Injection Drug Users - Pierce County, Washington, 2000
MMWR: May 18, 2001 / Vol. 50 / No. 19; 388-390, 399
Trends in Injection Drug Use Among Persons Entering Addiction Treatment - New Jersey, 1992-1999
MMWR: May 18, 2001 / Vol. 50 / No. 19; 378-381
Public Health and Injection Drug Use
MMWR: May 18, 2001 / Vol. 50 / No. 19; 378
Hepatitis C Risk Not Limited to Injection Drug Users
News release from the National Institutes of Health (NIH)
Women's Addiction Foundation
Resources for women affected by misuse/dependency on drugs/alcohol.
1
Centers for Disease Control and Prevention (CDC). Drug-Associated HIV Transmission Continues in the United States
2
CDC. HIV Prevention Strategic Plan Through 2005
3
CDC. Drug-Associated HIV Transmission Continues in the United States
4
CDC. Drug-Associated HIV Transmission Continues in the United States
